Helen of Troy (HELE) Q2 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2027 earnings summary
8 Oct, 2026Executive summary
Q2 sales rose 2.1% YoY to $440.9M; adjusted operating income increased 40.9% to $37.9M, and adjusted diluted EPS rose to $0.79 from $0.59.
FY27 earnings, EBITDA and cash-flow outlooks increased, while the sales range narrowed; priorities include restoring brand momentum, strengthening accountability and reducing debt.
Financial highlights
Q2 gross profit rose 20.7% to $230.1M and gross margin expanded 8.0 percentage points to 52.2%; tariff refunds net of higher tariff costs contributed ~560 bps, alongside lower trade and promotional expense.
Adjusted EBITDA increased to $49.4M from $36.2M; adjusted EBITDA margin improved to 11.2% from 8.4%.
Adjusted operating margin rose to 8.6% from 6.2%; GAAP net income was $4.6M, versus a $308.6M loss in the prior-year quarter, which included $326.4M of impairment charges.
H1 sales grew 4.9% to $843.0M; adjusted diluted EPS declined 4.0% to $0.96, while H1 net income was $40.4M versus a $759.4M loss.
H1 free cash flow was $38.3M, up from $23.0M; higher cash earnings and lower inventory and interest payments were partly offset by receivables, incentive payouts and taxes.
Outlook and guidance
FY27 sales outlook narrowed to $1.768B–$1.822B, or a 1.0% decline to 2.0% growth; Home & Outdoor is forecast at $851M–$876M and Beauty & Wellness at $917M–$946M.
Adjusted EBITDA guidance rose to $203M–$210M; adjusted diluted EPS to $3.60–$4.15, including a $0.30–$0.45 after-tax tariff-refund benefit.
Base-business adjusted EBITDA guidance remained $193M–$196M and base-business adjusted EPS guidance narrowed to $3.30–$3.70; consolidated guidance includes tariff refunds.
Operating cash flow outlook increased to $163M–$179M and free cash flow to $120M–$140M; FY27 capex is $39M–$43M.
Outlook includes ~$80.5M in tariff refunds, with 83%–88% reinvested and a $10M–$14M net pre-tax benefit; year-end net leverage target is no more than 2.7x.
Latest events from Helen of Troy
- Board rejects $37-per-share proposal, backing standalone plan and higher FY2027 outlook.HELE
Proxy filing - Board rejects $37 offer as execution improves and FY27 outlook rises.HELE
Investor presentation - Board rejects $37 cash bid, backing a multi-year growth and deleveraging plan.HELE
Proxy filing - All proposals passed, with a renewed focus on operational excellence and consumer-driven growth.HELE
AGM 2026 - Sales up 8.2% to $402.1M; GAAP EPS $1.51; 2027 outlook raised amid margin and cost pressures.HELE
Q1 2027 - Shareholders will vote on key governance, compensation, and equity plan changes amid ongoing transformation.HELE
Proxy filing - Board recommends approval of all proposals, including director elections and compensation.HELE
Proxy filing - Net loss driven by asset impairments and lower sales, with guidance reflecting ongoing tariff headwinds.HELE
Q3 2026 - Q2 sales and margins fell, but guidance, cash flow, and $500M buyback remain on track.HELE
Q2 2025